Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications avec texte intégral
Open Access
53 %
Mots clés
Antisense oligonucleotides
Dystrophie Myotonique
Alternative splicing
Intermediate filament
Dynamin 2
Hypoxia
Centronuclear myopathy
RNA interference
Motoneuron
Neuron
Gene Therapy
GSK3
Glucocorticoid-receptor
Fibrosis
Duchenne muscular dystrophy
Therapy
Trinucleotide repeat expansion
Animals
Mouse models
Brain
CMS
Myotonic Dystrophy
Autophagy
CRISPRi
Glial cells
Exercise
Heart
Acetylcholinesterase deficiency
Gene therapy
Brain dysfunction
Myotonic dystrophy
Myelin
GABA
CONGENITAL MYATHENIC SYNDROME
Oligodendrocytes
Mice
Thérapie génique
Exercice
In vivo
Dystrophin
Dystrophie myotonique
Myostatin
Myotonic dystrophy type 1
AAV
Knockout
KNOCKOUT MICE
Heart failure
Long read sequencing
Glutamate
CTG repeat instability
Myotonic Dystrophy Type 1
Astrocytes
Gene editing
Cytoskeleton
CRISPR/Cas9
Cell culture model
MBNL
CTG repeats
Endurance training
ARN
Transcriptomics
Transgenic mouse
DMPK
Transgenic mouse model
CTG repeat contractions
Expression
DMSXL mice
Skeletal muscle
Diaphragm
Myotonic dystrophy mouse models
Astrocyte
Central nervous system
Acetylcholinesterase knockout mouse
RNA biology
Maximal force
Oligodendrocyte
Mouse model
Humans
Dilated cardiomyopathy
Cell model
PCR
Desmin
Antisense oligonucleotide
ACETYLCHOLINESTERASE
RNA splicing
BIOLOGIE MOLECULAIRE
Muscular dystrophy
Cell penetrating peptide
Quantitative microdialysis
DM1
Acute coronary syndrome
Muscle
Trinucleotide Repeat Expansion
Cardiac muscle
Myotonic Dystrophy type 1
PacBio
Genotype phenotype correlation
Male
Glucocorticoids
Aging